• Je něco špatně v tomto záznamu ?

Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant

J. Ito, R. Suzuki, K. Uriu, Y. Itakura, J. Zahradnik, KT. Kimura, S. Deguchi, L. Wang, S. Lytras, T. Tamura, I. Kida, H. Nasser, M. Shofa, MM. Begum, M. Tsuda, Y. Oda, T. Suzuki, J. Sasaki, K. Sasaki-Tabata, S. Fujita, K. Yoshimatsu, H. Ito, N....

. 2023 ; 14 (1) : 2671. [pub] 20230511

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23011449

In late 2022, various Omicron subvariants emerged and cocirculated worldwide. These variants convergently acquired amino acid substitutions at critical residues in the spike protein, including residues R346, K444, L452, N460, and F486. Here, we characterize the convergent evolution of Omicron subvariants and the properties of one recent lineage of concern, BQ.1.1. Our phylogenetic analysis suggests that these five substitutions are recurrently acquired, particularly in younger Omicron lineages. Epidemic dynamics modelling suggests that the five substitutions increase viral fitness, and a large proportion of the fitness variation within Omicron lineages can be explained by these substitutions. Compared to BA.5, BQ.1.1 evades breakthrough BA.2 and BA.5 infection sera more efficiently, as demonstrated by neutralization assays. The pathogenicity of BQ.1.1 in hamsters is lower than that of BA.5. Our multiscale investigations illuminate the evolutionary rules governing the convergent evolution for known Omicron lineages as of 2022.

1st Medical Faculty at Biocev Charles University Vestec Prague Czechia

AMED CREST Japan Agency for Medical Research and Development Tokyo Japan

Center for Animal Disease Control University of Miyazaki Miyazaki Japan

Center for iPS Cell Research and Application Kyoto University Kyoto Japan

Collaboration Unit for Infection Joint Research Center for Human Retrovirus infection Kumamoto University Kumamoto Japan

CREST Japan Science and Technology Agency Kawaguchi Japan

Department of Biomolecular Sciences Weizmann Institute of Science Rehovot Israel

Department of Cancer Pathology Faculty of Medicine Hokkaido University Sapporo Japan

Department of Clinical Pathology Faculty of Medicine Suez Canal University Ismailia Egypt

Department of Global Health Promotion Tokyo Medical and Dental University Tokyo Japan

Department of Medicinal Sciences Graduate School of Pharmaceutical Sciences Kyushu University Fukuoka Japan

Department of Microbiology and Immunology Faculty of Medicine Hokkaido University Sapporo Japan

Department of Veterinary Science Faculty of Agriculture University of Miyazaki Miyazaki Japan

Division of International Research Promotion International Institute for Zoonosis Control Hokkaido University Sapporo Japan

Division of Molecular Pathobiology International Institute for Zoonosis Control Hokkaido University Sapporo Japan

Division of Molecular Virology and Genetics Joint Research Center for Human Retrovirus infection Kumamoto University Kumamoto Japan

Division of Risk Analysis and Management International Institute for Zoonosis Control Hokkaido University Sapporo Japan

Division of Systems Virology Department of Microbiology and Immunology The Institute of Medical Science The University of Tokyo Tokyo Japan

Graduate School of Frontier Sciences The University of Tokyo Kashiwa Japan

Graduate School of Medicine and Veterinary Medicine University of Miyazaki Miyazaki Japan

Graduate School of Medicine The University of Tokyo Tokyo Japan

HiLung Inc Kyoto Japan

Institute for Chemical Reaction Design and Discovery Hokkaido University Sapporo Japan

Institute for Genetic Medicine Hokkaido University Sapporo Japan

Institute for Vaccine Research and Development HU IVReD Hokkaido University Sapporo Japan

International Collaboration Unit International Institute for Zoonosis Control Hokkaido University Sapporo Japan

International Research Center for Infectious Diseases The Institute of Medical Science The University of Tokyo Tokyo Japan

International Vaccine Design Center The Institute of Medical Science The University of Tokyo Tokyo Japan

Interpark Kuramochi Clinic Utsunomiya Japan

Laboratory of Medical Virology Institute for Life and Medical Sciences Kyoto University Kyoto Japan

Laboratory of Virus Control Research Institute for Microbial Diseases Osaka University Suita Japan

Medical Research Council University of Glasgow Centre for Virus Research Glasgow UK

One Health Research Center Hokkaido University Sapporo Japan

Tokyo Metropolitan Institute of Public Health Tokyo Japan

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011449
003      
CZ-PrNML
005      
20230801133042.0
007      
ta
008      
230718s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41467-023-38188-z $2 doi
035    __
$a (PubMed)37169744
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Ito, Jumpei $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan $1 https://orcid.org/0000000304408321
245    10
$a Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant / $c J. Ito, R. Suzuki, K. Uriu, Y. Itakura, J. Zahradnik, KT. Kimura, S. Deguchi, L. Wang, S. Lytras, T. Tamura, I. Kida, H. Nasser, M. Shofa, MM. Begum, M. Tsuda, Y. Oda, T. Suzuki, J. Sasaki, K. Sasaki-Tabata, S. Fujita, K. Yoshimatsu, H. Ito, N. Nao, H. Asakura, M. Nagashima, K. Sadamasu, K. Yoshimura, Y. Yamamoto, T. Nagamoto, J. Kuramochi, G. Schreiber, Genotype to Phenotype Japan (G2P-Japan) Consortium, A. Saito, K. Matsuno, K. Takayama, T. Hashiguchi, S. Tanaka, T. Fukuhara, T. Ikeda, K. Sato
520    9_
$a In late 2022, various Omicron subvariants emerged and cocirculated worldwide. These variants convergently acquired amino acid substitutions at critical residues in the spike protein, including residues R346, K444, L452, N460, and F486. Here, we characterize the convergent evolution of Omicron subvariants and the properties of one recent lineage of concern, BQ.1.1. Our phylogenetic analysis suggests that these five substitutions are recurrently acquired, particularly in younger Omicron lineages. Epidemic dynamics modelling suggests that the five substitutions increase viral fitness, and a large proportion of the fitness variation within Omicron lineages can be explained by these substitutions. Compared to BA.5, BQ.1.1 evades breakthrough BA.2 and BA.5 infection sera more efficiently, as demonstrated by neutralization assays. The pathogenicity of BQ.1.1 in hamsters is lower than that of BA.5. Our multiscale investigations illuminate the evolutionary rules governing the convergent evolution for known Omicron lineages as of 2022.
650    _2
$a zvířata $7 D000818
650    _2
$a křečci praví $7 D006224
650    12
$a COVID-19 $7 D000086382
650    _2
$a fylogeneze $7 D010802
650    _2
$a SARS-CoV-2 $x genetika $7 D000086402
650    _2
$a substituce aminokyselin $7 D019943
650    _2
$a biotest $7 D001681
650    _2
$a neutralizující protilátky $7 D057134
650    _2
$a protilátky virové $7 D000914
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Suzuki, Rigel $u Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan
700    1_
$a Uriu, Keiya $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan $u Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
700    1_
$a Itakura, Yukari $u Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan $1 https://orcid.org/0000000234631834
700    1_
$a Zahradnik, Jiri $u Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel $u First Medical Faculty at Biocev, Charles University, Vestec-Prague, Czechia $1 https://orcid.org/0000000286984236
700    1_
$a Kimura, Kanako Terakado $u Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan
700    1_
$a Deguchi, Sayaka $u Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan
700    1_
$a Wang, Lei $u Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan $u Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Japan $1 https://orcid.org/000000016145395X
700    1_
$a Lytras, Spyros $u Medical Research Council-University of Glasgow Centre for Virus Research, Glasgow, UK $1 https://orcid.org/0000000342026682
700    1_
$a Tamura, Tomokazu $u Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan
700    1_
$a Kida, Izumi $u Division of Risk Analysis and Management, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan $1 https://orcid.org/0000000263121454
700    1_
$a Nasser, Hesham $u Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan $u Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt $1 https://orcid.org/0000000191631665
700    1_
$a Shofa, Maya $u Department of Veterinary Science, Faculty of Agriculture, University of Miyazaki, Miyazaki, Japan $u Graduate School of Medicine and Veterinary Medicine, University of Miyazaki, Miyazaki, Japan
700    1_
$a Begum, Mst Monira $u Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan
700    1_
$a Tsuda, Masumi $u Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan $u Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Japan $1 https://orcid.org/0000000154005905
700    1_
$a Oda, Yoshitaka $u Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan
700    1_
$a Suzuki, Tateki $u Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan $1 https://orcid.org/0000000269463850
700    1_
$a Sasaki, Jiei $u Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan
700    1_
$a Sasaki-Tabata, Kaori $u Department of Medicinal Sciences, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan
700    1_
$a Fujita, Shigeru $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan $u Graduate School of Medicine, The University of Tokyo, Tokyo, Japan $1 https://orcid.org/0000000190082123
700    1_
$a Yoshimatsu, Kumiko $u Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan $1 https://orcid.org/0000000200622753
700    1_
$a Ito, Hayato $u Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan
700    1_
$a Nao, Naganori $u Division of International Research Promotion, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan $u One Health Research Center, Hokkaido University, Sapporo, Japan $u Institute for Vaccine Research and Development: HU-IVReD, Hokkaido University, Sapporo, Japan
700    1_
$a Asakura, Hiroyuki $u Tokyo Metropolitan Institute of Public Health, Tokyo, Japan
700    1_
$a Nagashima, Mami $u Tokyo Metropolitan Institute of Public Health, Tokyo, Japan
700    1_
$a Sadamasu, Kenji $u Tokyo Metropolitan Institute of Public Health, Tokyo, Japan
700    1_
$a Yoshimura, Kazuhisa $u Tokyo Metropolitan Institute of Public Health, Tokyo, Japan
700    1_
$a Yamamoto, Yuki $u HiLung, Inc, Kyoto, Japan
700    1_
$a Nagamoto, Tetsuharu $u HiLung, Inc, Kyoto, Japan
700    1_
$a Kuramochi, Jin $u Interpark Kuramochi Clinic, Utsunomiya, Japan $u Department of Global Health Promotion, Tokyo Medical and Dental University, Tokyo, Japan $1 https://orcid.org/0000000290780527
700    1_
$a Schreiber, Gideon $u Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel $1 https://orcid.org/0000000229225882
700    1_
$a Saito, Akatsuki $u Department of Veterinary Science, Faculty of Agriculture, University of Miyazaki, Miyazaki, Japan $u Graduate School of Medicine and Veterinary Medicine, University of Miyazaki, Miyazaki, Japan $u Center for Animal Disease Control, University of Miyazaki, Miyazaki, Japan $1 https://orcid.org/0000000227924399
700    1_
$a Matsuno, Keita $u Division of Risk Analysis and Management, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan $u Institute for Vaccine Research and Development: HU-IVReD, Hokkaido University, Sapporo, Japan $u International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan $1 https://orcid.org/0000000242056526
700    1_
$a Takayama, Kazuo $u Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan $u AMED-CREST, Japan Agency for Medical Research and Development (AMED), Tokyo, Japan
700    1_
$a Hashiguchi, Takao $u Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan. hashiguchi.takao.1a@kyoto-u.ac.jp $1 https://orcid.org/0000000175787571
700    1_
$a Tanaka, Shinya $u Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan. tanaka@med.hokudai.ac.jp $u Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Japan. tanaka@med.hokudai.ac.jp $1 https://orcid.org/0000000164703301
700    1_
$a Fukuhara, Takasuke $u Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan. fukut@pop.med.hokudai.ac.jp $u AMED-CREST, Japan Agency for Medical Research and Development (AMED), Tokyo, Japan. fukut@pop.med.hokudai.ac.jp $u Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Suita, Japan. fukut@pop.med.hokudai.ac.jp $1 https://orcid.org/0000000154718331
700    1_
$a Ikeda, Terumasa $u Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan. ikedat@kumamoto-u.ac.jp $1 https://orcid.org/0000000328699450
700    1_
$a Sato, Kei $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. KeiSato@g.ecc.u-tokyo.ac.jp $u Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. KeiSato@g.ecc.u-tokyo.ac.jp $u International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. KeiSato@g.ecc.u-tokyo.ac.jp $u International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. KeiSato@g.ecc.u-tokyo.ac.jp $u Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan. KeiSato@g.ecc.u-tokyo.ac.jp $u Collaboration Unit for Infection, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan. KeiSato@g.ecc.u-tokyo.ac.jp $u CREST, Japan Science and Technology Agency, Kawaguchi, Japan. KeiSato@g.ecc.u-tokyo.ac.jp $1 https://orcid.org/0000000344311380
710    2_
$a Genotype to Phenotype Japan (G2P-Japan) Consortium
773    0_
$w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 14, č. 1 (2023), s. 2671
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37169744 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801133039 $b ABA008
999    __
$a ok $b bmc $g 1963701 $s 1197714
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 14 $c 1 $d 2671 $e 20230511 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

    Možnosti archivace